Condition
Valvular Heart Disease Patients
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Completed2
Not Yet Recruiting1
Enrolling By Invitation1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07489313Completed
Association of Prosthesis Types for Aortic or Mitral Valve Replacement With Long-term Risk of Mental Disorders
NCT07456085Phase 3Enrolling By InvitationPrimary
Rivaroxaban vs Warfarin in Patients With Mechanical Heart Valves
NCT07450287Not Yet Recruiting
CardioNETPOL National Registry of Carcinoid Heart Disease
NCT07023510Not ApplicableRecruitingPrimary
The VALVE-AI Trial
NCT02720549Not ApplicableCompletedPrimary
The Effect of Remote Ischemic Postconditioning on Postoperative Renal Dysfunction in Patients Undergoing Valvular Heart Surgery
Showing all 5 trials